A new water-soluble iron(III) sequestering agent has been designed. The tris-bidentate tripodal ligand consists of three 2,2′-dihydroxybiphenyl subunits connected via amide linkages at their meta (4-) positions to a framework of the “tren” type. The key step of the synthesis involves the coupling of suitably substituted monophenyl moieties in order to obtain the biphenyl precursor. The deprotonation constants of the ligand, and the formation and deprotonation constants of the FeIII complex have been determined from potentiometric and spectrophotometric measurements. The results are compared with those of a previously described homologous ligand in which the chelating subunits are attached to the tren framework via the ortho (3-) position of the biphenyl rather than the 4-position.
No takes yet. Share an insight, caveat, or question.
Baret et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: